Nasonex®(mometasone furoate monohydrate) – New partial over-the-counter approval
March 17, 2022 - Perrigo announced the approval of partial over-the counter (OTC) use of Merck’s Nasonex 24HR Allergy (mometasone furoate monohydrate) 50 mcg nasal spray, to temporarily relieve symptoms of hay fever or other upper respiratory allergies including nasal congestion, sneezing, runny and itchy nose in patients 2 years of age and older.
Top